Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 39.39M
March 31, 2026 -77.17M
December 31, 2025 40.20M
September 30, 2025 -3.303M
June 30, 2025 -16.64M
March 31, 2025 -15.44M
December 31, 2024 -15.43M
September 30, 2024 -18.18M
June 30, 2024 -20.13M
March 31, 2024 -13.82M
December 31, 2023 -12.46M
September 30, 2023 -13.70M
June 30, 2023 -13.39M
March 31, 2023 -41.86M
December 31, 2022 -12.10M
September 30, 2022 -15.09M
June 30, 2022 -17.02M
March 31, 2022 -10.38M
December 31, 2021 -10.79M
Date Value
September 30, 2021 -11.14M
June 30, 2021 -9.526M
March 31, 2021 -9.134M
December 31, 2020 -6.71M
September 30, 2020 -7.057M
June 30, 2020 -6.516M
March 31, 2020 -7.534M
December 31, 2019 -7.996M
September 30, 2019 -7.935M
June 30, 2019 -8.366M
March 31, 2019 -8.603M
December 31, 2018 1.48M
September 30, 2018 -6.632M
June 30, 2018 -7.364M
March 31, 2018 -10.62M
December 31, 2017 -6.593M
September 30, 2017 -6.815M
June 30, 2017 -6.905M
March 31, 2017 -9.658M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Indaptus Therapeutics, Inc. -1.795M
ACADIA Pharmaceuticals, Inc. 31.50M
Alnylam Pharmaceuticals, Inc. 164.49M
Savara, Inc. -40.23M
Vericel Corp. 2.206M

Net Income (Quarterly) Related Metrics